NCT06340750View on ClinicalTrials.gov

BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus

PHASE1RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

April 15, 2026

Study Completion Date

June 15, 2026

Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL

LMY-920

CAR T Therapy

Trial Locations (1)

43205

RECRUITING

Nationwide Children's, Columbus

Sponsors
All Listed Sponsors
collaborator

Nationwide Children

UNKNOWN

lead

Luminary Therapeutics

INDUSTRY